What is he best known for?
The fields of study he is best known for:
- Neuron
- Neurotransmitter
- Neuroscience
The scientist’s investigation covers issues in Neuroscience, Nociception, Amygdala, Neuroplasticity and Central nucleus of the amygdala.
His Neuroscience research includes themes of Neurotransmission and Metabotropic glutamate receptor.
His Neurotransmission study combines topics from a wide range of disciplines, such as Metabotropic glutamate receptor 1 and Posterior Horn Cell.
His Nociception research incorporates elements of Neuroimaging, Neuropathic pain and Electrophysiology.
His Amygdala study which covers Emotionality that intersects with Sprague dawley, Electric stimulation and Affect.
Laterality, Monoarthritis and Neuron is closely connected to Receptive field in his research, which is encompassed under the umbrella topic of Central nucleus of the amygdala.
His most cited work include:
- The Amygdala and Persistent Pain (530 citations)
- Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. (304 citations)
- Metabotropic glutamate receptors: novel targets for pain relief. (276 citations)
What are the main themes of his work throughout his whole career to date?
Volker Neugebauer mostly deals with Neuroscience, Amygdala, Metabotropic glutamate receptor, Central nucleus of the amygdala and Nociception.
His Neuroscience study integrates concerns from other disciplines, such as Synaptic plasticity, Postsynaptic potential and Neurotransmission.
His study in Amygdala is interdisciplinary in nature, drawing from both Emotionality, Prefrontal cortex, Electrophysiology and Kindling.
The concepts of his Metabotropic glutamate receptor study are interwoven with issues in Bicuculline, Glutamatergic, Pharmacology and Metabotropic receptor.
His Central nucleus of the amygdala research is multidisciplinary, incorporating perspectives in NMDA receptor, Microdialysis and Neuron.
His research in Nociception intersects with topics in Limbic system and Spinal cord.
He most often published in these fields:
- Neuroscience (87.50%)
- Amygdala (45.31%)
- Metabotropic glutamate receptor (39.06%)
What were the highlights of his more recent work (between 2012-2018)?
- Neuroscience (87.50%)
- Amygdala (45.31%)
- Inhibitory postsynaptic potential (14.06%)
In recent papers he was focusing on the following fields of study:
Volker Neugebauer mainly focuses on Neuroscience, Amygdala, Inhibitory postsynaptic potential, Excitatory postsynaptic potential and Neurotransmission.
The study incorporates disciplines such as Analgesic and Metabotropic glutamate receptor 5, Metabotropic glutamate receptor in addition to Neuroscience.
His work carried out in the field of Amygdala brings together such families of science as Serotonin reuptake inhibitor, Serotonin, Microdialysis, Neuroplasticity and Anxiogenic.
Volker Neugebauer interconnects NMDA receptor, Neural facilitation, Pharmacology and Arthritis in the investigation of issues within Microdialysis.
His work focuses on many connections between Inhibitory postsynaptic potential and other disciplines, such as Neuropeptide S, that overlap with his field of interest in Basolateral amygdala, Antagonist, Electrophysiology and Anxiolytic.
He has included themes like Central nucleus of the amygdala and Postsynaptic potential in his Excitatory postsynaptic potential study.
Between 2012 and 2018, his most popular works were:
- Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses (64 citations)
- Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain. (44 citations)
- CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (43 citations)
In his most recent research, the most cited papers focused on:
- Neuron
- Neurotransmitter
- Neuroscience
His primary areas of study are Amygdala, Neuroscience, Internal medicine, Central nucleus of the amygdala and Endocrinology.
His Amygdala research is multidisciplinary, incorporating elements of Pyramidal cell, Prefrontal cortex, Endocannabinoid system, Cannabinoid receptor and Metabotropic glutamate receptor 5.
His work deals with themes such as Agonist and Metabotropic glutamate receptor, which intersect with Neuroscience.
His research in the fields of κ-opioid receptor, Hyperalgesia, Diffuse noxious inhibitory control and Opioid overlaps with other disciplines such as Dynorphin.
Volker Neugebauer has researched Central nucleus of the amygdala in several fields, including Morphine, Postsynaptic potential, NMDA receptor, Neurotransmission and Rostral ventromedial medulla.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
